According to ResMed's latest financial reports the company's current EPS (TTM) is โน526.12. In 2022 the company made an earnings per share (EPS) of โน471.46 an increase over its 2021 EPS that were of โน305.76.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน508.30 | 7.81% |
2022 | โน471.46 | 54.19% |
2021 | โน305.76 | -25.88% |
2020 | โน412.53 | 52.37% |
2019 | โน270.75 | 0.63% |
2018 | โน269.04 | 55.94% |
2017 | โน172.53 | -12.17% |
2016 | โน196.44 | -7.63% |
2015 | โน212.67 | -0.4% |
2014 | โน213.52 | 9.65% |
2013 | โน194.73 | 12.32% |
2012 | โน173.38 | -10.18% |
2011 | โน193.02 | 58.6% |
2010 | โน121.71 | 23.91% |
2009 | โน98.22 | 44.65% |
2008 | โน67.90 | 96.3% |
2007 | โน34.59 | -41.3% |
2006 | โน58.93 | 35.29% |
2005 | โน43.56 | 9.68% |
2004 | โน39.72 | 20% |
2003 | โน33.10 | 27.05% |
2002 | โน26.05 | 159.57% |
2001 | โน10.04 | -43.37% |
2000 | โน17.72 | 25.76% |
1999 | โน14.09 | 45.05% |
1998 | โน9.72 | 54.24% |
1997 | โน6.30 | 28.26% |
1996 | โน4.91 |